{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:33:15Z","timestamp":1791487995038,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jacl.2016.07.002","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T13:27:02Z","timestamp":1469107622000},"page":"1081-1090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":163,"title":["The risks of statin use in pregnancy: A systematic review"],"prefix":"10.1016","volume":"10","author":[{"given":"Dean G.","family":"Karalis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alethea N.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Clifton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2016.07.002_bib1","unstructured":"U.S Food and Drug Administration. Available at: http:\/\/www.fda.gov. Accessed May 3,\u00a02016."},{"key":"10.1016\/j.jacl.2016.07.002_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/tera.1420500604","article-title":"Developmental toxicity of the HMG-CoA reductase inhibitor, atorvastatin, in rats and rabbits","volume":"50","author":"Dostal","year":"1994","journal-title":"Teratology"},{"key":"10.1016\/j.jacl.2016.07.002_bib3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/tera.1420280316","article-title":"Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase","volume":"28","author":"Minsker","year":"1983","journal-title":"Teratology"},{"key":"10.1016\/j.jacl.2016.07.002_bib4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2015.09.002","article-title":"National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2","volume":"9","author":"Jacobson","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2016.07.002_bib5","unstructured":"Women with FH and pregnancy. Available at: https:\/\/thefhfoundation.org. Accessed May 3,\u00a02016."},{"key":"10.1016\/j.jacl.2016.07.002_bib6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00228-008-0546-y","article-title":"Prescription drug use during pregnancy: a population based study in Regione Emilia-Romagna, Italy","volume":"64","author":"Gagne","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jacl.2016.07.002_bib7","doi-asserted-by":"crossref","first-page":"720.e1","DOI":"10.1016\/j.ajog.2015.12.038","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","volume":"214","author":"Costantine","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jacl.2016.07.002_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0890-6238(96)00130-X","article-title":"Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy","volume":"10","author":"Manson","year":"1996","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jacl.2016.07.002_bib9","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJM200404083501524","article-title":"Central nervous system and limb anomalies in case reports of first-trimester statin exposure","volume":"350","author":"Edison","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2016.07.002_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajmg.a.30386","article-title":"Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins","volume":"131A","author":"Edison","year":"2004","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jacl.2016.07.002_bib11","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/bdra.20181","article-title":"Pregnancy outcomes after maternal exposure to simvastatin and lovastatin","volume":"73","author":"Pollack","year":"2005","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.jacl.2016.07.002_bib12","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/ajmg.a.32493","article-title":"Maternal exposure to statins and risk for birth defects: A case-series approach","volume":"146A","author":"Peterson","year":"2008","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jacl.2016.07.002_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.reprotox.2008.06.009","article-title":"Prenatal exposure to HMG-CoA reductase inhibitors: Effects on fetal and neonatal outcome","volume":"26","author":"Taguchi","year":"2008","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jacl.2016.07.002_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/1471-0528.12066","article-title":"Pregnancy outcome following maternal exposure to statins: a multicenter prospective study","volume":"120","author":"Winterfield","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.jacl.2016.07.002_bib15","doi-asserted-by":"crossref","first-page":"h1035","DOI":"10.1136\/bmj.h1035","article-title":"Statins and\u00a0congenital malformations: cohort study","volume":"350","author":"Bateman","year":"2015","journal-title":"Br Med J"},{"key":"10.1016\/j.jacl.2016.07.002_bib16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2125.2007.02905.x","article-title":"Risk of congenital anomalies in pregnant users of statin drugs","volume":"64","author":"Ofori","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacl.2016.07.002_bib17","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/pds.1995","article-title":"Linking a pharmaceutical claims database with a birth defects registry to investigate birth defect rates of suspected teratogens","volume":"19","author":"Colvin","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jacl.2016.07.002_bib18","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIRCULATIONAHA.110.990929","article-title":"Pregnancy outcomes in familial hypercholesterolemia a registry-based study","volume":"124","author":"Toleikyte","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2016.07.002_bib19","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S1701-2163(16)32656-1","article-title":"Risk of statin use during pregnancy: a systematic review","volume":"29","author":"Kazmin","year":"2007","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jacl.2016.07.002_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1586\/erc.11.196","article-title":"Statin use during pregnancy: a systematic review and meta-analysis","volume":"10","author":"Kusters","year":"2012","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jacl.2016.07.002_bib21","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1345\/aph.1R202","article-title":"Teratogenic risk of statins in pregnancy","volume":"46","author":"Godrey","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacl.2016.07.002_bib22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1586\/17474108.2013.842684","article-title":"Are statins teratogenic in humans? Addressing the safety of statins in light of potential benefits during pregnancy","volume":"8","author":"Zarek","year":"2013","journal-title":"Expert Rev Obstet Gynecol"},{"key":"10.1016\/j.jacl.2016.07.002_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/bmj.38856.692986.AE","article-title":"Perinatal mortality and congenital anomalies in babies of women with Type 1 or Type 2 diabetes in England, Wales, and Northern Ireland: population based study","volume":"333","author":"Macintosh","year":"2006","journal-title":"Br Med J"},{"key":"10.1016\/j.jacl.2016.07.002_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3810\/pgm.2008.09.1920","article-title":"Maternal obesity and pregnancy","volume":"120","author":"Satpathy","year":"2008","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jacl.2016.07.002_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/tera.1420490407","article-title":"On the use of affected controls to address recall bias in case-control studies of birth defects","volume":"49","author":"Khoury","year":"1994","journal-title":"Teratology"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287416302343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287416302343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T10:21:22Z","timestamp":1536574882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287416302343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1933287416302343"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2016.07.002","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The risks of statin use in pregnancy: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2016.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}